000309935 001__ 309935
000309935 005__ 20260220120944.0
000309935 0247_ $$2doi$$a10.1007/s00520-026-10395-6
000309935 0247_ $$2pmid$$apmid:41677914
000309935 0247_ $$2pmc$$apmc:PMC12901272
000309935 0247_ $$2ISSN$$a0941-4355
000309935 0247_ $$2ISSN$$a1433-7339
000309935 037__ $$aDKFZ-2026-00384
000309935 041__ $$aEnglish
000309935 082__ $$a610
000309935 1001_ $$00000-0002-6032-0239$$aPauge, Sophie$$b0
000309935 245__ $$aTowards the assessment of financial distress among cancer patients: a conceptual model of the financial effects of a tumour disease.
000309935 260__ $$aNew York,NY$$bSpringer$$c2026
000309935 3367_ $$2DRIVER$$aarticle
000309935 3367_ $$2DataCite$$aOutput Types/Journal article
000309935 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1771510538_3004204
000309935 3367_ $$2BibTeX$$aARTICLE
000309935 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000309935 3367_ $$00$$2EndNote$$aJournal Article
000309935 500__ $$a#NCTZFB9#
000309935 520__ $$aA conceptualisation of subjective financial distress as a consequence of a cancer diagnosis and treatment is still missing due to a lack of a comprehensive model accounting for all relevant dimensions of financial effects of cancer experienced by patients. Our goal was to derive a model for the German healthcare system to shed light on the complex process of financial effects of cancer.The model was developed through systematic literature review and qualitative studies, including interviews with 18 cancer patients and a focus group with 4 social services representatives. The iterative process of model development was accompanied by an ongoing exchange in the interdisciplinary research team.The developed model of financial effects of cancer experienced by patients consists of three dimensions: (1) actual and anticipated financial disadvantages, (2) behavioural and cognitive coping strategies, and (3) subjective financial distress conceptualised as negative effects in different aspects of daily living: employment, living situation, family, social participation, health promoting lifestyle, additional personally preferred treatments, navigating the health system, and a further area so-called unspecific.Subjective financial distress is driven by different financial effects of cancer experienced by patients and is perceived as negative in various aspects of daily living. While the identified categories of daily living can be observed in countries with universal healthcare coverage, the content and degree of each subcategory depend on country-specific characteristics. The introduced model can be used to inform the development of a new patient-reported outcome measure (PROM).NCT05319925 (registration date, 2022-06-01).
000309935 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000309935 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000309935 650_7 $$2Other$$aCancer
000309935 650_7 $$2Other$$aConceptual model
000309935 650_7 $$2Other$$aCoping strategies
000309935 650_7 $$2Other$$aFinancial distress
000309935 650_7 $$2Other$$aFinancial toxicity
000309935 650_7 $$2Other$$aPatient-reported outcome
000309935 650_7 $$2Other$$aPatients
000309935 650_7 $$2Other$$aQualitative research
000309935 650_7 $$2Other$$aSocial services
000309935 650_2 $$2MeSH$$aHumans
000309935 650_2 $$2MeSH$$aNeoplasms: economics
000309935 650_2 $$2MeSH$$aNeoplasms: psychology
000309935 650_2 $$2MeSH$$aNeoplasms: therapy
000309935 650_2 $$2MeSH$$aFinancial Stress: economics
000309935 650_2 $$2MeSH$$aFinancial Stress: psychology
000309935 650_2 $$2MeSH$$aAdaptation, Psychological
000309935 650_2 $$2MeSH$$aMale
000309935 650_2 $$2MeSH$$aFemale
000309935 650_2 $$2MeSH$$aMiddle Aged
000309935 650_2 $$2MeSH$$aGermany
000309935 650_2 $$2MeSH$$aFocus Groups
000309935 650_2 $$2MeSH$$aAdult
000309935 650_2 $$2MeSH$$aCost of Illness
000309935 650_2 $$2MeSH$$aAged
000309935 650_2 $$2MeSH$$aActivities of Daily Living
000309935 650_2 $$2MeSH$$aQualitative Research
000309935 7001_ $$00000-0001-5540-780X$$aZüger, Andrea$$b1
000309935 7001_ $$aRichter, Luise$$b2
000309935 7001_ $$aMathies, Viktoria$$b3
000309935 7001_ $$00000-0003-1655-0907$$aSurmann, Bastian$$b4
000309935 7001_ $$00000-0003-2147-489X$$aErnst, Thomas$$b5
000309935 7001_ $$00000-0003-1106-474X$$aMenold, Natalja$$b6
000309935 7001_ $$00000-0001-9552-6969$$aGreiner, Wolfgang$$b7
000309935 7001_ $$0P:(DE-He78)c6e045b5f8796951c9f8b2a535372c30$$aWinkler, Eva$$b8$$udkfz
000309935 7001_ $$00000-0001-6532-9876$$aMehlis, Katja$$b9
000309935 773__ $$0PERI:(DE-600)1463166-0$$a10.1007/s00520-026-10395-6$$gVol. 34, no. 3, p. 190$$n3$$p190$$tSupportive care in cancer$$v34$$x0941-4355$$y2026
000309935 909CO $$ooai:inrepo02.dkfz.de:309935$$pVDB
000309935 9101_ $$0I:(DE-588b)2036810-0$$60000-0001-5540-780X$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000309935 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c6e045b5f8796951c9f8b2a535372c30$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000309935 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000309935 9141_ $$y2026
000309935 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-11-12$$wger
000309935 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2025-11-12$$wger
000309935 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-11-12
000309935 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-11-12
000309935 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-11-12
000309935 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-11-12
000309935 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-11-12
000309935 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-11-12
000309935 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-11-12
000309935 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSUPPORT CARE CANCER : 2022$$d2025-11-12
000309935 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-11-12
000309935 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-11-12
000309935 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2025-11-12
000309935 9201_ $$0I:(DE-He78)HD02-20160331$$kHD02$$lKoordinierungsstelle NCT Heidelberg$$x0
000309935 980__ $$ajournal
000309935 980__ $$aVDB
000309935 980__ $$aI:(DE-He78)HD02-20160331
000309935 980__ $$aUNRESTRICTED